110 related articles for article (PubMed ID: 241357)
1. Pharmacokinetics of a new beta-adrenoceptor blocking agent, LF 17-895, in man.
Gugler R; Kreis L; Dengler HJ
Arzneimittelforschung; 1975 Jul; 25(7):1067-72. PubMed ID: 241357
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U
Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of mepindolol in healthy volunteers after oral doses of mepindolol sulphate.
Krause W; Schwartzkopff W
Arzneimittelforschung; 1983; 33(9):1306-7. PubMed ID: 6685513
[TBL] [Abstract][Full Text] [Related]
5. Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.
Morita S; Iinuma M; Kido M; Sakuragi S; Kohri H; Nishino H
Arzneimittelforschung; 1977; 27(12):2380-3. PubMed ID: 23800
[TBL] [Abstract][Full Text] [Related]
6. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
[TBL] [Abstract][Full Text] [Related]
8. On the pharmacokinetics of talinolol, a new beta 1-receptor blocking agent.
Haustein KO; Fritzsche K
Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):392-5. PubMed ID: 6117520
[TBL] [Abstract][Full Text] [Related]
9. [The pharmacokinetics of Oral-Turinabol in humans].
Schumann W
Pharmazie; 1991 Sep; 46(9):650-4. PubMed ID: 1798729
[TBL] [Abstract][Full Text] [Related]
10. [Studies on pharmacokinetics and biotransformation of ipratropiumbromide in man (author's transl)].
Adlung J; Höhle KD; Zeren S; Wahl D
Arzneimittelforschung; 1976; 26(5a):1005-10. PubMed ID: 134721
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man.
Houin G; Barre J; Jeanniot JP; Ledudal P; Cautreels W; Tillement JP
Int J Clin Pharmacol Res; 1984; 4(3):175-83. PubMed ID: 6149195
[TBL] [Abstract][Full Text] [Related]
13. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs.
Matsunaga T; Tanabe H; Mochizuki T; Okabe K; Arizono H; Taneda M; Sato H; Ishii S; Sato J; Kiyoki M
Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676
[TBL] [Abstract][Full Text] [Related]
14. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopharmacological studies with pindolol following intravenous and oral administration].
Aellig WH
Adv Clin Pharmacol; 1976; 11():9-13. PubMed ID: 1032575
[TBL] [Abstract][Full Text] [Related]
16. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of amosulalol, an alpha, beta-adrenoceptor blocker, in rats, dogs and monkeys.
Kamimura H; Sasaki H; Kawamura S
Xenobiotica; 1984 Aug; 14(8):613-20. PubMed ID: 6149656
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of vinpocetine in humans.
Vereczkey L; Czira G; Tamás J; Szentirmay Z; Botár Z; Szporny L
Arzneimittelforschung; 1979; 29(6):957-60. PubMed ID: 582791
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
Zuidema J; Verhoeven J; Merkus FW
Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics and metabolite pattern of clenbuterol in the rat].
Kopitar Z; Zimmer A
Arzneimittelforschung; 1976; 26(7a):1435-41. PubMed ID: 1036935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
